Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lithium citrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Priadel 520mg/5ml liquid
0402030P0BCAAAI
|
Priadel (Liquid) | Lithium citrate | Central Nervous System | 1,664 |
|
Li-Liquid 509mg/5ml oral solution
0402030P0BDAAAL
|
Li-Liquid | Lithium citrate | Central Nervous System | 294 |
|
Lithium citrate 520mg/5ml oral solution sugar free
0402030P0AAAIAI
|
Lithium citrate | Lithium citrate | Central Nervous System | 249 |
|
Lithium citrate 509mg/5ml oral solution
0402030P0AAALAL
|
Lithium citrate | Lithium citrate | Central Nervous System | 149 |
|
Li-Liquid 1.018g/5ml oral solution
0402030P0BDABAK
|
Li-Liquid | Lithium citrate | Central Nervous System | 97 |
|
Lithium citrate 1.018g/5ml oral solution
0402030P0AAAKAK
|
Lithium citrate | Lithium citrate | Central Nervous System | 42 |
|
Litarex 564mg modified-release tablets
0402030P0BBAAAB
|
Litarex | Lithium citrate | Central Nervous System | No data available |
|
Lithium citrate 564mg modified-release tablets
0402030P0AAABAB
|
Lithium citrate | Lithium citrate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.